| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699976 | Clinical Oncology | 2007 | 4 Pages |
Abstract
We describe a novel 'de novo' TP53 mutation and discuss the importance of molecular testing in early-onset breast cancer patients and its effect on the management and outcome of the disease.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A. Salmon, D. Amikam, N. Sodha, S. Davidson, L. Basel-Vanagaite, R.A. Eeles, D. Abeliovich, T. Peretz,